Daily COVID-19 cases in India dropped below 75,000 and less than 1,000 deaths were reported in a day after nearly a month, while total recoveries crossed the 51 lakh-mark, according to the Union Health Ministry's data updated on Tuesday.
The total coronavirus cases in the country mounted to 61,45, 291 with 70,589 new infections, while the death toll reached 96,318 after 776 people succumbed to the disease in a span of 24 hours, the data updated at 8 am showed.
The total recoveries surged to 51,01,397 pushing the recovery rate to 83.01 per cent.
There are 9,47,576 active cases in the country which comprise 15.42 per cent of the total caseload, the data stated.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The COVID-19 case fatality rate was recorded at 1.57 per cent.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16 and crossed 60-lakh mark on September 28.
According to the ICMR, a cumulative total of 7,31,10,041 samples have been tested up to September 28 with 11,42,811 samples being tested on Monday.
The 776 new fatalities include180 from Maharashtra,70from Tamil Nadu,59 from Karnataka,58 from Uttar Pradesh,56from West Bengal, 46from Punjab, 37 each from Andhra Pradesh and Delhi and35 from Madhya Pradesh.
Total 96,318 deaths reported so far in the country include 35,751 from Maharashtra followed by 9,383 from Tamil Nadu, 8,641 from Karnataka, 5,745 from Andhra Pradesh, 5,652 from Uttar Pradesh,5,272 from Delhi,4,837 from West Bengal, 3,428 from Gujarat, 3,284 from Punjab and 2,242 from Madhya Pradesh.
The health ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities."Our figures are being reconciled with the Indian Council of Medical Research," the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.